scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...856211L |
P356 | DOI | 10.1371/JOURNAL.PONE.0056211 |
P932 | PMC publication ID | 3570459 |
P698 | PubMed publication ID | 23424651 |
P5875 | ResearchGate publication ID | 235670899 |
P50 | author | Min-Chuan Huang | Q56971865 |
Ji-Shiang Hung | Q59697431 | ||
P2093 | author name string | John Huang | |
Chia-Hua Chen | |||
Miao-Juei Huang | |||
Ming-Ting Chen | |||
Ya-Hsin Chen | |||
Jian Lee | |||
P2860 | cites work | Histopathology of Vascular Anomalies | Q56567233 |
Cloning and expression of human core 1 beta1,3-galactosyltransferase | Q24291836 | ||
Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice | Q24652041 | ||
The splice variants of vascular endothelial growth factor (VEGF) and their receptors | Q28200155 | ||
Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma | Q28216461 | ||
Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition | Q28238040 | ||
Cosmc is an essential chaperone for correct protein O-glycosylation | Q28506209 | ||
Hemangiomas in children | Q30732724 | ||
The sweet and sour of cancer: glycans as novel therapeutic targets | Q34439560 | ||
The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression | Q34622638 | ||
Cancer vaccines and carbohydrate epitopes | Q35525289 | ||
Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. | Q35747092 | ||
Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas | Q35764279 | ||
Regulation of protein O-glycosylation by the endoplasmic reticulum-localized molecular chaperone Cosmc | Q36817899 | ||
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma | Q36995485 | ||
Mucin-type O-glycosylation and its potential use in drug and vaccine development | Q36995685 | ||
Recent insights into the biological roles of mucin-type O-glycosylation | Q37130137 | ||
Infantile hemangiomas: how common are they? A systematic review of the medical literature | Q37145076 | ||
Carbohydrate vaccines: developing sweet solutions to sticky situations? | Q37426039 | ||
The Tn antigen-structural simplicity and biological complexity | Q37831859 | ||
Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor | Q39459644 | ||
Targeted disruption of the gene encoding core 1 beta1-3-galactosyltransferase (T-synthase) causes embryonic lethality and defective angiogenesis in mice | Q48365705 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageQuant | Q112270642 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
cell growth | Q189159 | ||
infantile hemangioma | Q52771370 | ||
overexpression | Q61643320 | ||
P304 | page(s) | e56211 | |
P577 | publication date | 2013-02-12 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | COSMC is overexpressed in proliferating infantile hemangioma and enhances endothelial cell growth via VEGFR2. | |
P478 | volume | 8 |
Q34867993 | Biology of infantile hemangioma |
Q47983641 | Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis |
Q37727574 | Identification of a novel protein binding motif within the T-synthase for the molecular chaperone Cosmc |
Q39327604 | Infantile Periocular Hemangioma |
Q38667341 | Knockdown of VEGFR2 inhibits proliferation and induces apoptosis in hemangioma-derived endothelial cells |
Q26996608 | Signaling pathways in the development of infantile hemangioma |
Q38966611 | Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen |